USA: Pharma´s lobbying 2000-2018

.  

As Washington aims to rein in soaring drug prices, the lobbying spending by drugmakers has reached a 10-year high.

The spending by the industry’s main trade group and seven key drugmakers has climbed to a level not seen in a decade

Ver